Together, we can see IPF differently
Boehringer Ingelheim is pleased to announce the launch of our new website for healthcare professionals interested in idiopathic pulmonary fibrosis (IPF). On the website, you will find up-to-date material on diagnosis of IPF and management of IPF, and insight into the impact of IPF on patients. We hope you will take the time to explore and see what the website has to offer. We are continuing to work on new IPF information and resources so do check back again soon for frequent updates.
ATS 2016 is approaching: View schedule of ILD sessions.
Patient cases are endorsed by WASOG
(World association for Sarcoidosis and Other Granulomatous Diseases)